Informationen für Intensivmediziner
COVID-19 CRF
This is an international resource for facilitating the collection of standardised clinical data on patients hospitalised with suspected or confirmed infection with novel coronavirus (COVID-19). The Case Record Form (CRF) has undergone extensive review and validation by international clinical experts.
https://isaric.tghn.org/novel-coronavirus/
REMAP-CAP
REMAP-CAP is a global network of leading experts, institutions and research networks. With over fifty sites participating world-wide, REMAP-CAP is a truly global trial. REMAP-CAP has submitted for approval to implement the Pandemic Appendix to the Core Protocol so that the platform can respond rapidly in the event of widespread disease resulting from the novel 2019 coronavirus (COVID-19). Additional domains are have been constructed with the capacity to evaluate different antiviral medications (Lopinavir/ritonavir), as well as additional immune modulation strategies (interferon-beta-1a [IFN-β1a], anakinra i.e. interleukin-1 receptor antagonist [IL1Ra]) in severe coronavirus infection.
For more information regarding study participation in Germany, please contact: sepsis@med.uni-jena.de
EMCrit Project
Dieser Blog von Josh Farkas, Pulmologe und Intensivmediziner, Vermont ist zugleich präzise und übersichtlich:
World Health Organization (WHO)
- A Multi-centre, Adaptive, Randomized,Double-BlindPlacebo-Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19
- Coronavirus-Outline of designs for experimental vaccines and therapeutics